APA (7th ed.) Citation

Mirzazadeh, H., Ghaeminia, Y., Niaei, A. M., Kamran, M., Jahromi, L. R., & Moshfeghinia, R. Memantine augmentation of escitalopram in treatment of executive function among patients with obsessive-compulsive disorder (OCD): A double-blind placebo-controlled randomized clinical trial. BMC.

Chicago Style (17th ed.) Citation

Mirzazadeh, Hasan, Younes Ghaeminia, Amin Mohamad Niaei, Mohammadsadegh Kamran, Leila Razeghian Jahromi, and Reza Moshfeghinia. Memantine Augmentation of Escitalopram in Treatment of Executive Function Among Patients with Obsessive-compulsive Disorder (OCD): A Double-blind Placebo-controlled Randomized Clinical Trial. BMC.

MLA (9th ed.) Citation

Mirzazadeh, Hasan, et al. Memantine Augmentation of Escitalopram in Treatment of Executive Function Among Patients with Obsessive-compulsive Disorder (OCD): A Double-blind Placebo-controlled Randomized Clinical Trial. BMC.